<DOC>
	<DOCNO>NCT01571141</DOCNO>
	<brief_summary>Human papillomavirus ( HPV ) infection worldwide problem strictly link development cervical cancer . Persistence infection one main factor responsible invasive progression woman diagnose intraepithelial squamous lesion refer assessment surgical treatment prone complication . Despite , several report spontaneous regression infection . In study investigator evaluate effectiveness long term polyhexamethylene biguanide ( PHMB ) -based local treatment improve viral clearance reduce time exposure infection avoid complication associate invasive treatment currently available . Women diagnose HPV infection randomly assign receive six month treatment PHMB-based gynaecological solution ( Monogin® ) remain untreated period time . The administration Monogin® perform every three day fifteen day every fifteen day subsequent six month .</brief_summary>
	<brief_title>Polyhexamethylene Biguanide Increases Regression Rate Human Papillomavirus ( HPV ) Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Polyhexamethylene biguanide</mesh_term>
	<criteria>pathologic Pap smear positive `` high risk '' HPV DNA test positive colposcopy examination patient undergone wart therapy previous six month pregnancy invasive disease immunosuppression previous HPV vaccination</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>HPV</keyword>
	<keyword>polyhexamethylene biguanide</keyword>
	<keyword>intraepithelial lesion</keyword>
	<keyword>regression rate</keyword>
</DOC>